Wuhan Zhongsheng YuJin Biomedicine

Wuhan Zhongsheng Yujin Biomedicine is a specialized biotechnology company based in Wuhan, China, operating as a subsidiary of China National Biotec Group (CNBG) under the Sinopharm umbrella. Founded in 2021, the company primarily focuses on the research, development, and industrialization of biological products, with a significant emphasis on vaccine production. It played a critical role in the manufacturing and supply of inactivated COVID-19 vaccines (Vero Cell) during the global pandemic. The company's facilities are integrated into the broader Sinopharm infrastructure, supporting large-scale production of essential immunotherapies and infectious disease preventatives. Located in the Wuhan Health Valley, the firm leverages advanced bioprocessing technologies to meet both domestic and international public health needs.